Anne Nagengast Johnson

Insider Reports History

Location
Berlin, Germany
Signature
/s/ Ryan Barrett, as attorney in fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne Nagengast Johnson:

Company Role Class Num Shares Value Price $ Report Date Ownership
ATAI Life Sciences N.V. Chief Financial Officer Common Shares 140,045 $189,061 $1.35 21 Mar 2025 Direct
ATAI Life Sciences N.V. Chief Financial Officer Stock Option 757,915 03 Mar 2025 Direct
AtaiBeckley Inc. Chief Financial Officer Stock Option 525,000 30 Jan 2026 Direct
AtaiBeckley Inc. Chief Financial Officer Restricted Stock Units 117,000 30 Jan 2026 Direct
ATAI Life Sciences N.V. Chief Financial Officer Restricted Stock Units 0 14 Mar 2025 Direct

Insider Reports Filed by Anne Nagengast Johnson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000114036126003551-johnson-anne-nagengast-2026-01-30 AtaiBeckley Inc. 30 Jan 2026 2 $0 4 Chief Financial Officer 03 Feb 2026, 18:54
ATAI ATAI Life Sciences N.V. 21 Mar 2025 1 -$45,286 4 Chief Financial Officer 24 Mar 2025, 21:00
ATAI ATAI Life Sciences N.V. 14 Mar 2025 2 $0 4 Chief Financial Officer 19 Mar 2025, 19:29
ATAI ATAI Life Sciences N.V. 03 Mar 2025 1 $0 4 Chief Financial Officer 05 Mar 2025, 16:28
ATAI ATAI Life Sciences N.V. 04 Oct 2024 4 $0 4 Chief Financial Officer 04 Oct 2024, 16:30
ATAI ATAI Life Sciences N.V. 02 Apr 2024 1 -$50,708 4 Chief Financial Officer 04 Apr 2024, 18:11
ATAI ATAI Life Sciences N.V. 13 Mar 2024 3 $0 4 Chief Financial Officer 15 Mar 2024, 20:16
ATAI ATAI Life Sciences N.V. 10 May 2023 0 $0 3 Chief Accounting Officer 19 May 2023, 17:36